Summary:
A PHASE 1 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED MODIFIED RNA VACCINE CANDIDATES AGAINST COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS
Qualified Participants Must:
• Must be 18 to 64 years old
• Have not received a Flu vaccine in the last 6 months
• Have only received Pfizer COVID vaccinations
• Have received 2 Pfizer COVID vaccinations and 1 Pfizer COVID booster
• Have received last Booster 150 to 365 days ago.